Dynamic 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography of liver tumours without blood sampling

European Journal of Nuclear Medicine

Volumn 27, Issue 4, 2000, Pages 407-412

  Keiding, Susanne ^a   Munk, Ole Lajord ^a   Schiøtt, Kirsten Marie ^a   Hansen, Søren B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

2 18F fluoro 2 deoxy D glucose; Blood sampling; Input function; Liver tumour; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; HUMAN; LIVER TUMOR; METABOLIC CLEARANCE RATE; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; ADENOCARCINOMA; ADOLESCENT; BILE DUCT CARCINOMA; BLOOD; CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; LIVER CELL CARCINOMA; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CARCINOMA; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033625145     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050523     Document Type: Article

References (22)

1. 1. Keiding S, Hansen SB, Rasmussen HH, et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998; 28: 700-706.
2. 2. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 1992; 33: 333-339.
3. 3. Hoh CK, Glaspy JA, Choi Y, et al. Quantitative dynamic and whole body PET FDG imaging of breast cancer. J Nucl Med 1992; 33: 823.
4. 4. Nieweg OE, Kim EE, Wong WH, et al. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 1993; 15 3920-3925.
5. 18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 1993; 17: 582-589.
6. 6. Newman JS, Francis IR, Kaminski MS, Wahl RL. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 1994; 190: 111-116.
7. 7. Wahl RL, Quint LE, Greenough RL, Meyer CH, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-377.
8. 8. Duhaylongsod FG, Lowe VJ, Patz EF, et al. Detection of primary and recurrent lung cancer by means of F-18-fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995; 110: 130-139.
9. 18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut 1995; 36: 771-777.
10. 18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 1996; 131: 703-707.
11. 11. Holder WD, White RL, Zuger JH, Easton EJ, Greene FL. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 1998; 227: 764-769.
12. 12. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. Staging of primary colorectal carcinomas with fluorine-18-fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998; 206: 755-760.
13. 13. Messa C, Choi Y, Hoh CK, et al. Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET. J Comput Assist Tomogr 1992; 16: 684-689.
14. 14. Gjedde A. High-and low-affinity transport of D-glucose from blood to brain. J Neurochem 1981; 36: 1463-1471.
15. 15. Gjedde A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res Rev 1982; 4: 237-274.
16. 16. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1-7.
17. 17. Wu HM, Hoh CK, Choi Y, et al. Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. J Nucl Med 1995; 36: 1714-1722.
18. 18. Weinberg IN, Huang SC, Hoffmann EJ, et al. Validation of PET-acquired input functions for cardiac studies. J Nucl Med 1998; 29: 241-247.
19. 19. Germano G, Chen BC, Huang SC, Gambhir SS, Hoffman EJ, Phelps ME. Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. J Nucl Med 1992; 33: 613-620.
20. 20. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer - a PET study. J Nucl Med 1993; 34: 1-6.
21. 21. Keiding S, Johansen S, Winkler K, Tønnesen K, Tygstrup N. Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liver. Am J Physiol 1976; 230: 1302-1313.
22. 22. Munk OL, Bender D, Roelsgaard K, Bass L, Keiding S. Liver metabolism in vivo by PET in pigs and humans: importance of modeling portal blood supply [abstract of the American Association for the Study of Liver Diseases, 50th Annual Meeting, 1999]). Hepatology 1999; 30 (Suppl): 321A.